These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34126105)

  • 1. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.
    Lackner C; Stauber RE; Davies S; Denk H; Dienes HP; Gnemmi V; Guido M; Miquel R; Paradis V; Schirmacher P; Terracciano L; Berghold A; Pregartner G; Binder L; Douschan P; Rainer F; Sygulla S; Jager M; Rautou PE; Bumbu A; Horhat A; Rusu I; Stefanescu H; Detlefsen S; Krag A; Thiele M; Cortez-Pinto H; Moreno C; Gouw ASH; Tiniakos DG
    J Hepatol; 2021 Oct; 75(4):810-819. PubMed ID: 34126105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
    Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
    J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis and alcohol-related liver disease.
    Lackner C; Tiniakos D
    J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.
    Spahr L; Rubbia-Brandt L; Genevay M; Hadengue A; Giostra E
    BMC Gastroenterol; 2011 Oct; 11():115. PubMed ID: 22035247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease.
    Israelsen M; Guerrero Misas M; Koutsoumourakis A; Huang Y; Thiele M; Hall A; Rasmussen D; Covelli C; Buzzetti E; Prat LI; Roccarina D; Detlefsen S; Luong TV; Quaglia A; Krag A; Jeffrey G; Pinzani M; Tsochatzis EA
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1728-1739. PubMed ID: 33044010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
    Sakhuja P
    World J Gastroenterol; 2014 Nov; 20(44):16474-9. PubMed ID: 25469015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
    Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis.
    Dubois M; Sciarra A; Trépo E; Marot A; Saldarriaga J; Moreno C; Sempoux C; Deltenre P
    United European Gastroenterol J; 2020 Nov; 8(9):1003-1012. PubMed ID: 32778003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease.
    Masson S; Emmerson I; Henderson E; Fletcher EH; Burt AD; Day CP; Stewart SF
    Liver Int; 2014 Feb; 34(2):235-42. PubMed ID: 23834275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.
    Lombardi R; Buzzetti E; Roccarina D; Tsochatzis EA
    World J Gastroenterol; 2015 Oct; 21(39):11044-52. PubMed ID: 26494961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive diagnosis and biomarkers in alcohol-related liver disease.
    Moreno C; Mueller S; Szabo G
    J Hepatol; 2019 Feb; 70(2):273-283. PubMed ID: 30658728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of histologically proven alcohol-related liver disease: A systematic review.
    Parker R; Aithal GP; Becker U; Gleeson D; Masson S; Wyatt JI; Rowe IA;
    J Hepatol; 2019 Sep; 71(3):586-593. PubMed ID: 31173814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.
    Bedossa P; Patel K
    Gastroenterology; 2016 Jun; 150(8):1811-1822.e4. PubMed ID: 27003601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.